Funding sources: none.
Alemtuzumab and chronic plaque psoriasis
Version of Record online: 8 JUL 2013
© 2013 The Authors BJD © 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 169, Issue 1, pages 184–186, July 2013
How to Cite
Aslam, A., Marsland, A.M., Rog, D. and Griffiths, C.E.M. (2013), Alemtuzumab and chronic plaque psoriasis. British Journal of Dermatology, 169: 184–186. doi: 10.1111/bjd.12226
Conflicts of interest: D.R. has been an investigator for a phase 3 trial of alemtuzumab and has received reimbursement through an internationally managed research fund. He has also received personal compensation for attending advisory boards for Sanofi Genzyme. C.E.M.G. has acted as a speaker and consultant for Abbott, Pfizer, Leo, Janssen, Novartis and MSD.
- Issue online: 8 JUL 2013
- Version of Record online: 8 JUL 2013